Data gathered: November 6
Alternative Data for Astrazeneca
About Astrazeneca
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.
| Price | $63.85 |
| Target Price | Sign up |
| Volume | 15,850,000 |
| Market Cap | $221B |
| Year Range | $63.77 - $87.62 |
| Dividend Yield | 2.08% |
| PE Ratio | 34.67 |
| Analyst Rating | 80% buy |
| Earnings Date | November 12 '24 |
| Industry | Drug Manufacturers |
In the news
 |
Stock Traders Buy Large Volume of Call Options on AstraZeneca (NASDAQ:AZN)November 5 - ETF Daily News |
 |
Market Chatter: Astrazeneca Shares Slump on Ongoing Probe Into Alleged Insurance FraudNovember 5 - Yahoo |
|
Stephens Inc. AR Cuts Stock Position in AstraZeneca PLC (NASDAQ:AZN)November 4 - ETF Daily News |
 |
Are Options Traders Betting on a Big Move in AstraZeneca (AZN) Stock?November 3 - Yahoo |
|
US Bancorp DE Buys 14,965 Shares of AstraZeneca PLC (NASDAQ:AZN)November 3 - ETF Daily News |
 |
Astrazeneca (AZN) Rises But Trails Market: What Investors Should KnowNovember 1 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 12.9B | 3.15B | 9.79B | 1.93B | 4.12B | 0.990 |
| Q1 '24 | 12.9B | 3.15B | 9.79B | 1.93B | 4.12B | 1.030 |
| Q4 '23 | 12.7B | 3.14B | 9.54B | 2.18B | 4.5B | 0.730 |
| Q3 '23 | 11.5B | 2.1B | 9.4B | 1.37B | 3.33B | 0.870 |
| Q2 '23 | 11.4B | 1.96B | 9.46B | 1.82B | 2.52B | 1.080 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$157.88 0.3% | 50 |
 |
Eli Lilly and CompanyLLY |
$776.38 3.7% | 63 |
 |
PfizerPFE |
$27.36 2.3% | 40 |
 |
AbbVieABBV |
$201.2 0.2% | 56 |
 |
TherapeuticsMDTXMD |
$1.54 0% | 39 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
| Michael McCaul Republican |
Sep 20, 23 | Sell | $100K - $250K |
| Michael McCaul Republican |
Sep 20, 23 | Sell | $50K - $100K |
Read more about Astrazeneca (AZN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Astrazeneca?
The Market Cap of Astrazeneca is $221B.
What is Astrazeneca's PE Ratio?
As of today, Astrazeneca's PE (Price to Earnings) ratio is 34.67.
When does Astrazeneca report earnings?
Astrazeneca will report its next earnings on November 12 '24.
What is the current stock price of Astrazeneca?
Currently, the price of one share of Astrazeneca stock is $63.85.
How can I analyze the AZN stock price chart for investment decisions?
The AZN stock price chart above provides a comprehensive visual representation of Astrazeneca's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Astrazeneca shares. Our platform offers an up-to-date AZN stock price chart, along with technical data analysis and alternative data insights.
Does AZN offer dividends to its shareholders?
Yes, Astrazeneca (AZN) offers dividends to its shareholders, with a dividend yield of 2.08%. This dividend yield represents Astrazeneca's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Astrazeneca in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Astrazeneca?
Some of the similar stocks of Astrazeneca are Johnson & Johnson, Eli Lilly and Company, Pfizer, AbbVie, and TherapeuticsMD.
.